MORRIS S. YOUNG - 28 Oct 2022 Form 4 Insider Report for AXT INC (AXTI)

Role: CHAIRMAN AND CEO, Director
Signature: /s/ /s/ Morris S Young, Attorney-in-Fact, Attorney-in-Fact
Issuer symbol: AXTI
Transactions as of: 28 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Nov 2022, 21:37:32 UTC
Previous filing: 16 Mar 2022
Next filing: 12 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXTI	Common Stock	Award	$0	+111,795	+5.6%	$0.000000	2,093,475	28 Oct 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This total includes 1,876,768 shares of common stock held by the Reporting Person and the Young Family Trust for which the Reporting Person serves as trustee; In 2019 two additional GRATS were established with 108,112 shares each for which the Reporting Person serves as trustee; and 483 shares of common stock held by the Morris Young Family Ltd. P artnership. The Reporting P erson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting P erson is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.

Content

This total includes 1,876,768 shares of common stock held by the Reporting Person and the Young Family Trust for which the Reporting Person serves as trustee; In 2019 two additional GRATS were established with 108,112 shares each for which the Reporting Person serves as trustee; and 483 shares of common stock held by the Morris Young Family Ltd. P artnership. The Reporting P erson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting P erson is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.